Back
Biogen, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
57
BIIB
Biogen, Inc.
Last Price:
$182.03
Seasonality Move:
9.63%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiBiogen, Inc. Stock Forecast
-
Over the next 52 weeks, Biogen, Inc. has on average historically risen by 35.3% based on the past 34 years of stock performance.
-
Biogen, Inc. has risen higher in 21 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.76%
-
Is Biogen, Inc. Stock Undervalued?The current Biogen, Inc. [BIIB] share price is $180.75. The Score for BIIB is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
BIIB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Biogen, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Biogen, Inc. has on average historically risen by 35.3% based on the past 34 years of stock performance.
Biogen, Inc. Stock Rating
Buy
57
Biogen, Inc. (BIIB)
is a Buy
Is Biogen, Inc. overpriced?
-
Biogen, Inc. has risen higher in 21 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.76%
Biogen, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biogen.com
52-Week Data
52-Week High:
185.17
52-Week Low:
110.04
Prediction Charts
Market Cap:
26.5B
Price in USD:
180.75
Volume:
1.8M
Beta:
0.86
Technical Analysis
SMA50:
156.11
SMA100:
145.71
SMA200:
138.01
52-Wk Change:
12.37%
Stock Predictions
-
Is Biogen, Inc. stock public?Yes, Biogen, Inc. is a publicly traded company.
-
What is the Biogen, Inc. stock quote today?The Biogen, Inc. stock price is 180.75 USD today.
-
How to buy Biogen, Inc. stock online?You can buy Biogen, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-13 | 161.57 | 164.73 | 167.87 | 161.20 |
| Nov-14 | 164.72 | 167.55 | 169.00 | 163.00 |
| Nov-17 | 167.00 | 164.68 | 167.97 | 163.50 |
| Nov-18 | 164.40 | 168.83 | 170.78 | 163.00 |
| Nov-19 | 168.83 | 167.93 | 168.90 | 165.79 |
| Nov-20 | 168.15 | 168.18 | 170.91 | 165.75 |
| Nov-21 | 168.54 | 175.30 | 176.02 | 167.42 |
| Nov-24 | 177.65 | 176.82 | 185.17 | 175.57 |
| Nov-25 | 177.07 | 181.96 | 182.97 | 176.09 |
| Nov-26 | 181.96 | 181.94 | 183.93 | 180.76 |
| Nov-28 | 182.07 | 182.09 | 182.74 | 180.69 |
| Dec-1 | 180.15 | 177.78 | 181.78 | 175.88 |
| Dec-2 | 177.32 | 180.18 | 180.55 | 174.53 |
| Dec-3 | 180.17 | 180.75 | 182.94 | 178.05 |
Biogen, Inc. Earnings
Biogen, Inc. Earnings Report: Per Share Biogen, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biogen, Inc. Forecast Revenue Growth
Biogen, Inc. Stock Analysis: Historical quarterly revenues per share for Biogen, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.32 per share, and an increase next year of $0.12 per share.
* Biogen, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.